Executive Summary

CLIA quality control meeting: Centers for Disease Control and Prevention schedules meeting for Sept. 25-26 to discuss "Quality Control Issues Relevant to Regulations Under the Clinical Laboratory Improvement Amendments" at CDC headquarters in Atlanta. Items on the agenda include: "the ability of current test systems to assess the potential for error in the total testing process"; "processes to monitor the quality of clinical laboratory results over time"; and "processes to assess appropriate operator performance." The committee will hear input from industry reps on the first day and other health professionals the second day; comments will be considered by CDC in the development of final CLIA regs for quality control. For further information, contact CDC's Julie Wasil at 770/488-4651...